Skip to main content

Table 1 Baseline characteristics of the NR study population (n = 854)

From: Machine learning to predict no reflow and in-hospital mortality in patients with ST-segment elevation myocardial infarction that underwent primary percutaneous coronary intervention

Variable

Normal blood flow (n = 755)

NR (n = 99)

p-value

Age (years)

60.34 (13.27)

62.79 (13.88)

0.086

Male (n (%))

628 (83.2)

74 (74.7)

0.039

Hypertension (n (%))

345 (45.7)

38 (38.4)

0.169

Diabetes (n (%))

124 (16.4)

12 (12.1)

0.271

Smoke (n (%))

377 (49.9)

34 (34.3)

0.004

Angina pectoris (n (%))

41 (5.4)

7 (7.1)

0.505

Previous PCI (n (%))

19 (2.5)

5 (5.1)

0.267

Anterior wall MI (n(%))

391 (51.8)

48 (48.5)

0.536

Cardiac troponin I (normalized)

0.47 (0.33)

0.67 (0.31)

 < 0.001

creatine kinase-MB (normalized)

0.13 (0.13)

0.22 (0.17)

 < 0.001

hs-CRP (normalized)

0.34 (0.33)

0.50 (0.39)

 < 0.001

Hemoglobin (g/L)

137.65 (19.28)

133.90 (19.60)

0.07

WBC count (109/L)

11.50 (3.94)

12.40 (3.78)

0.033

Creatinine (μmol/L)

89.68 (43.15)

99.38 (45.22)

0.037

Uric acid (μmol/L)

385.33 (118.53)

407.30 (135.37)

0.089

Albumin (g/L)

38.72 (4.37)

38.43 (4.91)

0.544

Glucose (mmol/L)

7.31 (3.44)

7.52 (2.84)

0.577

LDL-C (mmol/L)

3.28 (1.05)

3.12 (0.97)

0.156

HDL-C (mmol/L)

1.20 (0.44)

1.15 (0.32)

0.351

Triglyceride (mmol/L)

1.65 (1.13)

1.60 (1.25)

0.734

Total cholesterol (mmol/L)

5.01 (1.24)

4.89 (1.26)

0.347

Fibrinogen (g/L)

3.65 (1.08)

3.63 (1.24)

0.862

Shock (%)

13 (1.7)

7 (7.1)

0.003

Malignant arrhythmia (n (%))

90 (11.9)

18 (18.2)

0.078

Killip class (n (%))

 I

610 (80.8)

64 (64.6)

 < 0.001

 II

83 (11.0)

15 (15.2)

0.222

 III

15 (2.0)

3 (3.0)

0.758

 IV

47 (6.2)

17 (17.2)

 < 0.001

LVEF (%)

57.97 (9.15)

54.30 (10.16)

 < 0.001

Total ischemia time (h)

4.85 (3.51)

6.29 (5.61)

 < 0.001

SO-to-FMC (min)

157.21 (166.20)

262.06 (290.03)

 < 0.001

Door-to balloon (min)

85.68 (49.34)

88.53 (54.05)

0.594

Baseline TIMI flow

 0

581 (77.0)

90 (90.9)

0.001

 1

38 (5.0)

5 (5.1)

1.0

 2

77 (10.2)

1 (1.0)

0.003

 3

59 (7.8)

3 (3.0)

0.085

Criminal blood vessels (n (%))

 LAD

431 (57.3)

49 (49.5)

0.140

 LCX

56(7.4)

8 (8.1)

0.814

 RCA

263 (34.8)

41 (41.4)

0.199

 LM

5 (0.7)

1 (1.0)

0.524

Double or multiple lesions (n (%))

501 (66.4)

78 (78.8)

0.013

Post dilatation (n (%))

446 (59.1)

56 (56.6)

0.634

Thrombus aspiration (n (%))

84 (11.1)

29 (29.3)

 < 0.001

Stent diameter (mm)

3.14 (0.43)

3.14 (0.40)

0.895

Stent length (mm)

33.94 (17.25)

41.57 (18.78)

 < 0.001

  1. hs-CRP high-sensitivity C-reactive protein, HDL-C high-density lipoprotein cholesterol, LVEF left ventricular ejection fraction, LAD left anterior descending coronary artery, LCX left coronary circumflexus artery, LDL-C low-density lipoprotein cholesterol, LM left main coronary artery, MI myocardial infarction, PCI percutaneous transluminal coronary intervention, RCA right coronary artery, SO-to-FMC symptom-onset to-first medical contact, TIMI thrombolysis and thrombin inhibition in myocardial infarction